Digestive System Diseases
61
6
8
31
Key Insights
Highlights
Success Rate
84% trial completion
Published Results
11 trials with published results (18%)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
9.8%
6 terminated out of 61 trials
83.8%
-2.7% vs benchmark
8%
5 trials in Phase 3/4
35%
11 of 31 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 31 completed trials
Clinical Trials (61)
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Intestinal Organoids
Post-Market Study of the Signia Circular Stapler With Tri-Staple Technology in Left-sided Colon, Sigmoid, and Rectal Resections
Long-term Health Outcomes of Screen Detected and Potential Celiac Disease Patients
Efficacy of Guided Imagery Therapy Mobile Application for Functional Abdominal Pain
Efficacy and Safety of Grazoprevir (+) Uprifosbuvir (+) Ruzasvir (MK-3682B) (MK-5172 + MK-3682 + MK-8408) Fixed Dose Combination in Chronic HCV Participants Failing Prior Antiviral Treatment (MK-3682-021)
Point of Care 3D Ultrasound for Various Applications: A Pilot Study
89Zr-MMOT PET Imaging in Pancreatic and Ovarian Cancer Patients
Study of a Monoclonal Antibody KHK4083 in Moderate Ulcerative Colitis
Evaluate the Efficacy of Adding Intraluminal Brachytherapy After CCRT for Local-regional Thoracic Esophageal Cancer.
XELOX Combined With Anlotinib and Penpulimab vs XELOX as Adjuvant Therapy in ctDNA Positive Gastric and Esophagogastric Junction Adenocarcinoma
Efficacy and Safety of SOX Regimen Combined With Camrelizumab as Neoadjuvant Treatment in Locally Advanced Gastric Cancer: a Phase II, Single-arm Study
A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid Tumors
Nab-paclitaxel and Gemcitabine vs Gemcitabine Alone as Adjuvant Therapy for Patients With Resected Pancreatic Cancer (the "Apact" Study)
Evaluation of Ocoxin-Viusid® in Advanced Pancreatic Adenocarcinoma
Spanish Series of Patients Treated With the Radionuclide Lutetium177
Anlotinib Hydrochloride Capsules Combined With TQB2450 Injection in Esophageal Squamous Cell Carcinoma Patients
Research on the Application and Mechanism of New Biological Probes in Biomedicine
Anlotinib Hydrochloride Capsules Combined With CAPEOX in RAS and BRAF Wild-type mCRC Patients
A Phase 1, Multicenter, Open-Label Study to Evaluate the Effect of Mild or Moderate Hepatic Impairment on the Multiple-Dose Pharmacokinetics of Ozanimod